Risk factors

Allarity Therapeutics (ALLR) risk factors

Item 1A of every Allarity Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

  • FY2025 10-K risk factors
    90 risksNo changes

    This company faces no prior year comparisons for risk factor changes in this filing period.

    Filed Mar 30, 2026
  • FY2024 10-K risk factors
    90 risks

    Clinical stage biopharmaceutical company focused on developing stenoparib for ovarian cancer using its DRP platform.

    Filed Mar 31, 2025